更多...
收起
The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):]  原癌基因MET产品是肝细胞生长因子受体和编码酪氨酸激酶的活性。主单链前体蛋白质是翻译后切割产生的α和β亚基,它是二硫键连接以形成成熟受体。在MET基因的各种突变与乳头状肾癌有关。已发现该基因编码不同亚型的两个转录变异体。 [由RefSeq的,2008年7月提供]
MET基因(以及对应的蛋白质)的细胞分布位置:
MET基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Liver carcinoma | 0.339583541 | 36 | 0 | BeFree_CTD_human_LHGDN_RGD_UNIPROT |
Renal Cell Carcinoma | 0.253320515 | 32 | 7 | BeFree_CLINVAR_CTD_human_LHGDN |
Neoplasm Metastasis | 0.149616959 | 82 | 0 | BeFree_CTD_human_LHGDN |
Adenocarcinoma | 0.147495081 | 29 | 0 | BeFree_CTD_human_LHGDN |
Non-Small Cell Lung Carcinoma | 0.141443908 | 83 | 1 | BeFree_CTD_human |
Autistic Disorder | 0.140726728 | 16 | 1 | BeFree_CTD_human_GAD_LHGDN |
Lung Neoplasms | 0.137974753 | 13 | 1 | BeFree_CTD_human_LHGDN |
Squamous cell carcinoma | 0.128977445 | 15 | 2 | BeFree_CTD_human_LHGDN |
Glioblastoma | 0.128967513 | 25 | 0 | BeFree_CTD_human_LHGDN |
Osteosarcoma | 0.127891677 | 12 | 0 | BeFree_CTD_human_LHGDN |
Stomach Neoplasms | 0.12408156 | 7 | 0 | BeFree_CTD_human_LHGDN |
Schizophrenia | 0.122909916 | 2 | 0 | BeFree_CTD_human_GAD |
ovarian neoplasm | 0.12272435 | 2 | 0 | CTD_human_LHGDN |
Sinusitis | 0.122367032 | 2 | 0 | CTD_human_GAD |
Leukemia, Myelocytic, Acute | 0.120814326 | 3 | 0 | BeFree_CTD_human |
Esophageal Neoplasms | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Cognition Disorders | 0.12 | 1 | 0 | CTD_human |
Hepatitis, Chronic | 0.12 | 1 | 0 | CTD_human |
Liver Neoplasms, Experimental | 0.12 | 1 | 0 | CTD_human |
Neoplasm Invasiveness | 0.12 | 1 | 0 | CTD_human |
Neoplastic Syndromes, Hereditary | 0.12 | 0 | 1 | CLINVAR |
Neuroblastoma | 0.12 | 1 | 0 | CTD_human |
childhood hepatocellular carcinoma | 0.12 | 0 | 3 | CLINVAR |
Type 1 Papillary Renal Cell Carcinoma | 0.12 | 3 | 0 | UNIPROT |
Copper-Overload Cirrhosis | 0.12 | 1 | 0 | CTD_human |
Papillary renal cell carcinoma, familial | 0.12 | 0 | 0 | ORPHANET |
Malignant neoplasm of breast | 0.089229024 | 34 | 1 | BeFree_MGD |
Glioma | 0.08706742 | 18 | 0 | BeFree_LHGDN_RGD |
Cholangiocarcinoma | 0.086263026 | 6 | 0 | BeFree_LHGDN_RGD |
Pancreatic Neoplasm | 0.085362824 | 4 | 0 | BeFree_GAD_LHGDN_RGD |
Liver neoplasms | 0.084353001 | 8 | 0 | BeFree_LHGDN_RGD |
Endometrial Neoplasms | 0.082995792 | 2 | 0 | BeFree_LHGDN_RGD |
Liver Failure, Acute | 0.080271442 | 2 | 0 | BeFree_RGD |
Diabetes Mellitus, Experimental | 0.08 | 1 | 0 | RGD |
Cardiomegaly | 0.08 | 1 | 0 | RGD |
Hepatitis, Animal | 0.08 | 1 | 0 | RGD |
Liver Cirrhosis, Experimental | 0.08 | 1 | 0 | RGD |
Pancreatitis | 0.08 | 1 | 0 | RGD |
Periodontitis | 0.08 | 1 | 0 | RGD |
Reperfusion Injury | 0.08 | 1 | 0 | RGD |
Gilles de la Tourette syndrome | 0.08 | 0 | 0 | MGD |
AUTISM, SUSCEPTIBILITY TO, 9 | 0.08 | 0 | 0 | MGD |
Acute kidney injury | 0.08 | 1 | 0 | RGD |
Malignant neoplasm of lung | 0.023040222 | 53 | 2 | BeFree_GAD |
Colorectal Neoplasms | 0.019884777 | 10 | 0 | BeFree_LHGDN |
Stomach Carcinoma | 0.014929303 | 55 | 0 | BeFree |
Malignant neoplasm of stomach | 0.012486326 | 46 | 0 | BeFree |
Prostatic Neoplasms | 0.011168843 | 5 | 0 | BeFree_LHGDN |
Carcinoma of lung | 0.011129117 | 41 | 2 | BeFree |
Small cell carcinoma of lung | 0.010616028 | 11 | 1 | BeFree_LHGDN |
Carcinogenesis | 0.010586233 | 39 | 0 | BeFree |
Mammary Neoplasms | 0.008987376 | 6 | 2 | BeFree_LHGDN |
Breast Carcinoma | 0.008957582 | 33 | 1 | BeFree |
Tumor Progression | 0.007871814 | 29 | 0 | BeFree |
Colorectal Cancer | 0.007871814 | 29 | 0 | BeFree |
Colorectal Carcinoma | 0.007600372 | 28 | 0 | BeFree |
Rhabdomyosarcoma | 0.006534468 | 5 | 0 | BeFree_LHGDN |
Adenoma | 0.005991584 | 4 | 0 | BeFree_LHGDN |
Multiple Myeloma | 0.005167327 | 10 | 0 | BeFree_LHGDN |
Hereditary Papillary Renal Carcinoma | 0.004885954 | 18 | 0 | BeFree |
Sarcoma | 0.00408156 | 6 | 0 | BeFree_LHGDN |
Carcinoma, Papillary | 0.003810118 | 5 | 0 | BeFree_LHGDN |
Lymphoma | 0.003810118 | 5 | 0 | BeFree_LHGDN |
melanoma | 0.003800186 | 14 | 1 | BeFree |
Malignant neoplasm of prostate | 0.003528744 | 13 | 0 | BeFree |
Prostate carcinoma | 0.003528744 | 13 | 0 | BeFree |
Cystic Fibrosis | 0.003257302 | 12 | 0 | BeFree |
Ovarian Carcinoma | 0.003257302 | 12 | 0 | BeFree |
Renal carcinoma | 0.003257302 | 12 | 0 | BeFree |
Nasal Polyps | 0.003181358 | 3 | 0 | BeFree_GAD |
Amyotrophic Lateral Sclerosis | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Adult T-Cell Lymphoma/Leukemia | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Systemic Scleroderma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Thyroid Neoplasm | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Malignant tumor of colon | 0.002985861 | 11 | 0 | BeFree |
Colon Carcinoma | 0.002985861 | 11 | 0 | BeFree |
Malignant neoplasm of urinary bladder | 0.002909916 | 3 | 0 | BeFree_GAD |
Noninfiltrating Intraductal Carcinoma | 0.00272435 | 1 | 0 | LHGDN |
Colonic Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
Pathological accumulation of air in tissues | 0.00272435 | 1 | 0 | LHGDN |
Fatty Liver | 0.00272435 | 1 | 0 | LHGDN |
Lymphedema | 0.00272435 | 1 | 0 | LHGDN |
Metaplasia | 0.00272435 | 1 | 0 | LHGDN |
Nephritis | 0.00272435 | 1 | 0 | LHGDN |
Oropharyngeal Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
Purpura | 0.00272435 | 1 | 0 | LHGDN |
Skin Ulcer | 0.00272435 | 1 | 0 | LHGDN |
Plasma Cell Neoplasm | 0.00272435 | 1 | 0 | LHGDN |
Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.00272435 | 1 | 0 | LHGDN |
Adenocarcinoma of lung (disorder) | 0.002714419 | 10 | 0 | BeFree |
Malignant neoplasm of kidney | 0.002714419 | 10 | 0 | BeFree |
Myopia | 0.002638474 | 1 | 0 | BeFree_GAD |
Cancer of Head and Neck | 0.002638474 | 2 | 0 | BeFree_GAD |
Solid tumour | 0.002442977 | 9 | 0 | BeFree |
Neoplastic Cell Transformation | 0.002367032 | 1 | 0 | GAD |
Hyperparathyroidism, Secondary | 0.002367032 | 1 | 0 | GAD |
Chronic Obstructive Airway Disease | 0.002367032 | 1 | 0 | GAD |
Multiple Sclerosis | 0.002367032 | 1 | 1 | GAD |
Refractive Errors | 0.002367032 | 1 | 0 | GAD |
Rhinitis | 0.002367032 | 1 | 0 | GAD |
Squamous cell carcinoma of skin | 0.002367032 | 1 | 0 | GAD |
Atrial Septal Defects | 0.002171535 | 8 | 0 | BeFree |
Pancreatic carcinoma | 0.002171535 | 8 | 0 | BeFree |
Papillary thyroid carcinoma | 0.002171535 | 8 | 0 | BeFree |
Secondary malignant neoplasm of lymph node | 0.002171535 | 8 | 0 | BeFree |
Malignant neoplasm of ovary | 0.002171535 | 8 | 0 | BeFree |
Malignant neoplasm of pancreas | 0.001900093 | 7 | 0 | BeFree |
Osteosarcoma of bone | 0.001900093 | 7 | 0 | BeFree |
Malignant Pleural Mesothelioma | 0.001900093 | 7 | 0 | BeFree |
Autism Spectrum Disorders | 0.001900093 | 7 | 0 | BeFree |
Medulloblastoma | 0.001628651 | 6 | 0 | BeFree |
Secondary malignant neoplasm of liver | 0.001628651 | 6 | 0 | BeFree |
Squamous cell carcinoma of the head and neck | 0.001628651 | 6 | 0 | BeFree |
Kidney Neoplasm | 0.001357209 | 5 | 0 | BeFree |
Mesothelioma | 0.001357209 | 5 | 0 | BeFree |
Carcinoma breast stage IV | 0.001357209 | 5 | 1 | BeFree |
Adenocarcinoma Of Esophagus | 0.001357209 | 5 | 0 | BeFree |
Papillary Renal Cell Carcinoma | 0.001357209 | 5 | 0 | BeFree |
Brain Neoplasms | 0.001085767 | 4 | 0 | BeFree |
Chordoma | 0.001085767 | 4 | 0 | BeFree |
Secondary malignant neoplasm of bone | 0.001085767 | 4 | 0 | BeFree |
Adenocarcinoma, Clear Cell | 0.001085767 | 4 | 0 | BeFree |
Thyroid carcinoma | 0.001085767 | 4 | 1 | BeFree |
Epithelial ovarian cancer | 0.001085767 | 4 | 0 | BeFree |
Rhabdoid Tumor of the Kidney | 0.001085767 | 4 | 0 | BeFree |
Tumor Angiogenesis | 0.001085767 | 4 | 0 | BeFree |
Nasopharyngeal carcinoma | 0.001085767 | 4 | 0 | BeFree |
Trisomy | 0.000814326 | 3 | 0 | BeFree |
Diffuse Large B-Cell Lymphoma | 0.000814326 | 3 | 0 | BeFree |
Alveolar Soft Part Sarcoma | 0.000814326 | 3 | 0 | BeFree |
Gastric Adenocarcinoma | 0.000814326 | 3 | 0 | BeFree |
Squamous cell carcinoma of esophagus | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of liver | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of esophagus | 0.000814326 | 3 | 0 | BeFree |
Malignant Glioma | 0.000814326 | 3 | 0 | BeFree |
Colorectal cancer metastatic | 0.000814326 | 3 | 0 | BeFree |
Gastrooesophageal cancer | 0.000814326 | 3 | 0 | BeFree |
Adenoma of large intestine | 0.000814326 | 3 | 4 | BeFree |
Xenograft Model | 0.000814326 | 3 | 0 | BeFree |
Glioblastoma Multiforme | 0.000814326 | 3 | 0 | BeFree |
Astrocytoma | 0.000542884 | 2 | 0 | BeFree |
Bone neoplasms | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of endometrium | 0.000542884 | 2 | 0 | BeFree |
Bronchioloalveolar Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Adenocarcinoma, Scirrhous | 0.000542884 | 2 | 0 | BeFree |
Ulcerative Colitis | 0.000542884 | 2 | 0 | BeFree |
Fibrosarcoma | 0.000542884 | 2 | 0 | BeFree |
Von Hippel-Lindau Syndrome | 0.000542884 | 2 | 0 | BeFree |
Psychotic Disorders | 0.000542884 | 2 | 0 | BeFree |
Severe Combined Immunodeficiency | 0.000542884 | 2 | 0 | BeFree |
Sarcoma, Clear Cell | 0.000542884 | 2 | 0 | BeFree |
Leiomyomatosis | 0.000542884 | 2 | 0 | BeFree |
Uveal melanoma | 0.000542884 | 2 | 0 | BeFree |
Gastrointestinal Stromal Tumors | 0.000542884 | 2 | 0 | BeFree |
Multiple tumors | 0.000542884 | 2 | 0 | BeFree |
Liver and Intrahepatic Biliary Tract Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Conventional (Clear Cell) Renal Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Malignant mesothelioma | 0.000542884 | 2 | 0 | BeFree |
Nonorganic psychosis | 0.000542884 | 2 | 0 | BeFree |
Endometrial Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Carcinoma of bladder | 0.000542884 | 2 | 0 | BeFree |
Malignant Peripheral Nerve Sheath Tumor | 0.000542884 | 2 | 0 | BeFree |
Invasive Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Epithelioma | 0.000542884 | 2 | 0 | BeFree |
Hepatocarcinogenesis | 0.000542884 | 2 | 0 | BeFree |
Ovarian Clear Cell Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
Non-Neoplastic Disorder | 0.000542884 | 2 | 0 | BeFree |
Uterine Corpus Cancer | 0.000542884 | 2 | 0 | BeFree |
Hereditary Renal Cell Carcinoma | 0.000542884 | 2 | 2 | BeFree |
Acidosis, Lactic | 0.000271442 | 1 | 0 | BeFree |
Rheumatoid Arthritis | 0.000271442 | 1 | 0 | BeFree |
Bladder neck obstruction | 0.000271442 | 1 | 0 | BeFree |
Bladder Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Burkitt Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of thyroid | 0.000271442 | 1 | 0 | BeFree |
Carcinoma, Transitional Cell | 0.000271442 | 1 | 0 | BeFree |
Chondrosarcoma | 0.000271442 | 1 | 0 | BeFree |
Endometriosis | 0.000271442 | 1 | 0 | BeFree |
Gastrinoma | 0.000271442 | 1 | 0 | BeFree |
Giant Cell Tumors | 0.000271442 | 1 | 0 | BeFree |
Hepatitis B | 0.000271442 | 1 | 0 | BeFree |
Hepatitis C | 0.000271442 | 1 | 0 | BeFree |
Hodgkin Disease | 0.000271442 | 1 | 0 | BeFree |
Immunologic Deficiency Syndromes | 0.000271442 | 1 | 0 | BeFree |
Kidney Failure, Chronic | 0.000271442 | 1 | 0 | BeFree |
leukemia | 0.000271442 | 1 | 0 | BeFree |
Chronic Lymphocytic Leukemia | 0.000271442 | 1 | 0 | BeFree |
Leukemia, T-Cell | 0.000271442 | 1 | 0 | BeFree |
Liver Cirrhosis | 0.000271442 | 1 | 0 | BeFree |
Marijuana Abuse | 0.000271442 | 1 | 0 | BeFree |
Melanosis | 0.000271442 | 1 | 0 | BeFree |
Microphthalmos | 0.000271442 | 1 | 0 | BeFree |
Monoclonal Gammopathy of Undetermined Significance | 0.000271442 | 1 | 0 | BeFree |
Mucocutaneous Lymph Node Syndrome | 0.000271442 | 1 | 0 | BeFree |
Myocardial Infarction | 0.000271442 | 1 | 0 | BeFree |
Acoustic Neuroma | 0.000271442 | 1 | 0 | BeFree |
oligodendroglioma | 0.000271442 | 1 | 0 | BeFree |
Degenerative polyarthritis | 0.000271442 | 1 | 0 | BeFree |
Paresis | 0.000271442 | 1 | 0 | BeFree |
Pericardial effusion | 0.000271442 | 1 | 0 | BeFree |
Pleural effusion disorder | 0.000271442 | 1 | 0 | BeFree |
Polycythemia Vera | 0.000271442 | 1 | 0 | BeFree |
Adenomatous Polyposis Coli | 0.000271442 | 1 | 0 | BeFree |
Precancerous Conditions | 0.000271442 | 1 | 0 | BeFree |
Kidney Failure | 0.000271442 | 1 | 0 | BeFree |
Rett Syndrome | 0.000271442 | 1 | 0 | BeFree |
Gastric ulcer | 0.000271442 | 1 | 0 | BeFree |
Substance Dependence | 0.000271442 | 1 | 0 | BeFree |
synovial sarcoma | 0.000271442 | 1 | 0 | BeFree |
Thymoma | 0.000271442 | 1 | 0 | BeFree |
Unipolar Depression | 0.000271442 | 1 | 0 | BeFree |
Xeroderma Pigmentosum | 0.000271442 | 1 | 0 | BeFree |
Zollinger-Ellison syndrome | 0.000271442 | 1 | 0 | BeFree |
T-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Liver Failure | 0.000271442 | 1 | 0 | BeFree |
Benign Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of lung | 0.000271442 | 1 | 0 | BeFree |
Renal fibrosis | 0.000271442 | 1 | 0 | BeFree |
Muscle Weakness | 0.000271442 | 1 | 0 | BeFree |
Esophageal carcinoma | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of nasopharynx | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of lung | 0.000271442 | 1 | 0 | BeFree |
Mitochondrial Myopathies | 0.000271442 | 1 | 0 | BeFree |
Anaplastic carcinoma | 0.000271442 | 1 | 1 | BeFree |
Liposarcoma, Dedifferentiated | 0.000271442 | 1 | 0 | BeFree |
Neuroectodermal Tumors | 0.000271442 | 1 | 0 | BeFree |
Liposarcoma, Myxoid | 0.000271442 | 1 | 0 | BeFree |
Alveolar rhabdomyosarcoma | 0.000271442 | 1 | 0 | BeFree |
Adrenocortical carcinoma | 0.000271442 | 1 | 0 | BeFree |
Carcinoma, Large Cell | 0.000271442 | 1 | 0 | BeFree |
Cervical Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Neuroendocrine Tumors | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of salivary gland | 0.000271442 | 1 | 0 | BeFree |
Carcinoma of unknown primary | 0.000271442 | 1 | 0 | BeFree |
Metastatic malignant neoplasm to brain | 0.000271442 | 1 | 0 | BeFree |
Melanosis coli | 0.000271442 | 1 | 0 | BeFree |
Emotional disorder | 0.000271442 | 1 | 0 | BeFree |
Renal Cell Dysplasia | 0.000271442 | 1 | 0 | BeFree |
Cancer of Nasopharynx | 0.000271442 | 1 | 0 | BeFree |
Anaplastic thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
Medullary carcinoma of thyroid | 0.000271442 | 1 | 0 | BeFree |
Defect of diaphragm | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of stomach stage IV | 0.000271442 | 1 | 0 | BeFree |
Metastatic osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
stage, prostate cancer | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of oropharynx | 0.000271442 | 1 | 0 | BeFree |
Squamous cell carcinoma of tonsil | 0.000271442 | 1 | 0 | BeFree |
Desmoplastic Small Round Cell Tumor | 0.000271442 | 1 | 0 | BeFree |
Adenomatous goiter | 0.000271442 | 1 | 0 | BeFree |
Healing ulcer | 0.000271442 | 1 | 0 | BeFree |
Anaplastic astrocytoma | 0.000271442 | 1 | 0 | BeFree |
Epiretinal Membrane | 0.000271442 | 1 | 0 | BeFree |
Multiple malignancy | 0.000271442 | 1 | 0 | BeFree |
Malignant lymphoma of testis | 0.000271442 | 1 | 0 | BeFree |
Arrhythmogenic Right Ventricular Dysplasia | 0.000271442 | 1 | 0 | BeFree |
Impaired exercise tolerance | 0.000271442 | 1 | 0 | BeFree |
Ewings sarcoma | 0.000271442 | 1 | 0 | BeFree |
Tumor Initiation | 0.000271442 | 1 | 0 | BeFree |
Toxic Shock Syndrome | 0.000271442 | 1 | 0 | BeFree |
invasive cancer | 0.000271442 | 1 | 0 | BeFree |
Refractory cancer | 0.000271442 | 1 | 1 | BeFree |
Cancer Relapse | 0.000271442 | 1 | 0 | BeFree |
Poorly differentiated carcinoma | 0.000271442 | 1 | 0 | BeFree |
Well Differentiated Oligodendroglioma | 0.000271442 | 1 | 0 | BeFree |
Malignant Squamous Cell Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of lung, stage I | 0.000271442 | 1 | 0 | BeFree |
Ovarian adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
High-Grade Prostatic Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Major Depressive Disorder | 0.000271442 | 1 | 0 | BeFree |
Inflammatory disorder | 0.000271442 | 1 | 0 | BeFree |
Primary Effusion Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Congenital naevus | 0.000271442 | 1 | 0 | BeFree |
Congenital melanocytic nevus | 0.000271442 | 1 | 0 | BeFree |
Hereditary Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
Metastatic Malignant Peripheral Nerve Sheath Tumor | 0.000271442 | 1 | 0 | BeFree |
Pancreatic Ductal Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Differentiated Thyroid Gland Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Drug Dependence | 0.000271442 | 1 | 0 | BeFree |
Cancer Cell Growth | 0.000271442 | 1 | 0 | BeFree |
Secondary Glioblastoma | 0.000271442 | 1 | 0 | BeFree |
Non-Malignant Ascites Adverse Event | 0.000271442 | 1 | 0 | BeFree |
Cirrhosis | 0.000271442 | 1 | 0 | BeFree |
Benign Prostatic Hyperplasia | 0.000271442 | 1 | 0 | BeFree |
Mammographic Density | 0.000271442 | 1 | 0 | BeFree |
INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1 | 0.000271442 | 1 | 0 | BeFree |
Urothelial Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Familial renal cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
Proliferative Inflammatory Atrophy | 0.000271442 | 1 | 0 | BeFree |
Renal dysplasia | 0.000271442 | 1 | 0 | BeFree |
Triple Negative Breast Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Fibromyxosarcoma | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。